General fitness, health and nutrition · Public discussion

Food Restriction Increases Dopamine Receptor Levels in Obese Rats

Started by Sheldon · · Last activity · 2 posts · 150 views

This thread is locked and is currently read-only.

Thread details

What we know about this thread

Original section
General fitness, health and nutrition
Published
25 October 2007
Last activity
25 October 2007
Original author
Sheldon
Posts
2
Discussion status
Public discussion
Total views
150
Views / 30 days
0

The navigation and discussion metadata provide context. Posts remain in their original chronological order.

Showing posts 1–2 of 2
Posts remain in their original chronological order.

Text size
  1. The following news release is being issued today by the U.S.
    Department of Energy's Brookhaven National Laboratory. The release and
    accompanying images may also be viewed online at:
    http://www.bnl.gov/bnlweb/pubaf/pr/PR_display.asp?prID=07-97

    *********
    NEWS RELEASE
    Number: 07-97
    For release on Thursday, October 25, 2007

    Food Restriction Increases Dopamine Receptor Levels in Obese Rats

    Evidence for interplay of brain's "reward" chemical with availability
    of food in obesity

    UPTON, NY -- A brain-imaging study of genetically obese rats conducted
    at the U.S. Department of Energy's Brookhaven National Laboratory
    provides more evidence that dopamine - a brain chemical associated
    with reward, pleasure, movement, and motivation - plays a role in
    obesity. The scientists found that genetically obese rats had lower
    levels of dopamine D2 receptors than lean rats. They also demonstrated
    that restricting food intake can increase the number of D2 receptors,
    partially attenuating a normal decline associated with aging.

    "This research corroborates brain-imaging studies conducted at
    Brookhaven that found decreased levels of dopamine D2 receptors in
    obese people compared with normal-weight people," said Brookhaven
    neuroscientist Panayotis (Peter) Thanos, lead author of the current
    study, which will be published in the journal Synapse and is now
    available online.

    It's not clear whether reduced receptor levels are a cause or
    consequence of obesity: Overeating may chronically reduce receptor
    levels, which, over the long term, could eventually contribute to
    obesity. But having genetically low receptor levels may also lead to
    obesity by predisposing the individual to overeating in an attempt to
    stimulate a "blunted" reward system. Either way, revving up receptor
    levels by restricting food intake could enhance the impact of this
    common strategy for combating obesity.

    "Consuming fewer calories is obviously important for people trying to
    lose weight, plus improving the brain's ability to respond to rewards
    other than food may help prevent overeating," Thanos said. Because
    food intake can have such a dramatic effect on dopamine receptor
    levels, "this study also provides further evidence for the interplay
    of genetic factors with the environment in the development of obesity
    in our society," he said.

    The finding that food restriction can attenuate the effects of aging
    on the brain's ability to respond to dopamine may also help explain
    why food restriction slows down other changes associated with aging,
    such as declines in locomotor activity and sensitivity to reward.

    Study methods and main findings

    The researchers measured dopamine D2 receptor levels in adolescent and
    young adult genetically obese Zucker rats and lean rats. Between
    measures, half of the rats in each group were given free access to
    food while the other half were given 70 percent of the daily average
    amount of food eaten by the unrestricted group.

    The scientists measured D2 receptor levels using two different
    techniques: micro-positron emission tomography (microPET) in living
    animals, which uses a radioactively tagged molecule that competes with
    the brain's natural dopamine for D2 receptor binding sites, and
    autoradiography, which uses a tracer that binds more strongly than
    natural dopamine but can only be used in tissue samples rather than in
    living animals. Together these two methods indicate the absolute
    number of D2 receptors found in the brain and how many are available
    or free during day-to-day function, which might be relevant to further
    elucidating the role of dopamine in obesity.

    One main finding was that the overall number of D2 receptors was lower
    in obese than in lean rats. Also D2 receptor levels decreased with
    age, but this decline was significantly blunted in food-restricted
    rats compared with those given free access to food. This attenuation
    was most apparent in the obese rats.

    Another main finding was that D2 receptor availability - that is, the
    number of receptors available for binding dopamine - was greater at
    adulthood in the obese rats compared to the lean rats. This suggests
    that perhaps the release of dopamine had significantly decreased with
    age in the obese unrestricted animals more than in the restricted ones
    or the lean rats. The possibility of lower release of dopamine in
    obese subjects is presently being examined, the researchers say.

    This research was funded by the Office of Biological and Environmental
    Research within the U.S. Department of Energy's Office of Science and
    by the Intramural Research Program of the National Institute on
    Alcohol Abuse and Alcoholism, which is part of the National Institutes
    of Health.

    For more information about Peter Thanos's research, see http://www.bnl.gov/thanoslab.

    One of ten national laboratories overseen and primarily funded by the
    Office of Science of the U.S. Department of Energy (DOE), Brookhaven
    National Laboratory conducts research in the physical, biomedical, and
    environmental sciences, as well as in energy technologies and national
    security. Brookhaven Lab also builds and operates major scientific
    facilities available to university, industry and government
    researchers. Brookhaven is operated and managed for DOE's Office of
    Science by Brookhaven Science Associates, a limited-liability company
    founded by the Research Foundation of State University of New York on
    behalf of Stony Brook University, the largest academic user of
    Laboratory facilities, and Battelle, a nonprofit, applied science and
    technology organization.

    Visit Brookhaven Lab's electronic newsroom for links, news archives,
    graphics, and more: http://www.bnl.gov/newsroom
    --

    Sheldon

  2. THIS HEAR IS A LOTA INFORMASTION,. BUT; I AINT' HAD NO RAT PROBLEMES SINCE
    LEAVIN KENTUCKY. ACCORDIN TO THIS HEAR STUDY THEY MUST BE GITTIN PLENTY TO
    EAT,. A FAT RAT IS FOR SHURE EASYER SHOOTIN THAN A SKINNY ONE,;. AND JEST
    WHAT DOES THIS HAVE TO DO WITH FOOD.COOKIN.,?

    FATTY

    "Sheldon" <[email hidden]> wrote in message
    news:[email hidden]...

    Quoted message said:

    The following news release is being issued today by the U.S.
    Department of Energy's Brookhaven National Laboratory. The release and
    accompanying images may also be viewed online at:
    http://www.bnl.gov/bnlweb/pubaf/pr/PR_display.asp?prID=07-97

    *********
    NEWS RELEASE
    Number: 07-97
    For release on Thursday, October 25, 2007

    Food Restriction Increases Dopamine Receptor Levels in Obese Rats

    Evidence for interplay of brain's "reward" chemical with availability
    of food in obesity

    UPTON, NY -- A brain-imaging study of genetically obese rats conducted
    at the U.S. Department of Energy's Brookhaven National Laboratory
    provides more evidence that dopamine - a brain chemical associated
    with reward, pleasure, movement, and motivation - plays a role in
    obesity. The scientists found that genetically obese rats had lower
    levels of dopamine D2 receptors than lean rats. They also demonstrated
    that restricting food intake can increase the number of D2 receptors,
    partially attenuating a normal decline associated with aging.

    "This research corroborates brain-imaging studies conducted at
    Brookhaven that found decreased levels of dopamine D2 receptors in
    obese people compared with normal-weight people," said Brookhaven
    neuroscientist Panayotis (Peter) Thanos, lead author of the current
    study, which will be published in the journal Synapse and is now
    available online.

    It's not clear whether reduced receptor levels are a cause or
    consequence of obesity: Overeating may chronically reduce receptor
    levels, which, over the long term, could eventually contribute to
    obesity. But having genetically low receptor levels may also lead to
    obesity by predisposing the individual to overeating in an attempt to
    stimulate a "blunted" reward system. Either way, revving up receptor
    levels by restricting food intake could enhance the impact of this
    common strategy for combating obesity.

    "Consuming fewer calories is obviously important for people trying to
    lose weight, plus improving the brain's ability to respond to rewards
    other than food may help prevent overeating," Thanos said. Because
    food intake can have such a dramatic effect on dopamine receptor
    levels, "this study also provides further evidence for the interplay
    of genetic factors with the environment in the development of obesity
    in our society," he said.

    The finding that food restriction can attenuate the effects of aging
    on the brain's ability to respond to dopamine may also help explain
    why food restriction slows down other changes associated with aging,
    such as declines in locomotor activity and sensitivity to reward.

    Study methods and main findings

    The researchers measured dopamine D2 receptor levels in adolescent and
    young adult genetically obese Zucker rats and lean rats. Between
    measures, half of the rats in each group were given free access to
    food while the other half were given 70 percent of the daily average
    amount of food eaten by the unrestricted group.

    The scientists measured D2 receptor levels using two different
    techniques: micro-positron emission tomography (microPET) in living
    animals, which uses a radioactively tagged molecule that competes with
    the brain's natural dopamine for D2 receptor binding sites, and
    autoradiography, which uses a tracer that binds more strongly than
    natural dopamine but can only be used in tissue samples rather than in
    living animals. Together these two methods indicate the absolute
    number of D2 receptors found in the brain and how many are available
    or free during day-to-day function, which might be relevant to further
    elucidating the role of dopamine in obesity.

    One main finding was that the overall number of D2 receptors was lower
    in obese than in lean rats. Also D2 receptor levels decreased with
    age, but this decline was significantly blunted in food-restricted
    rats compared with those given free access to food. This attenuation
    was most apparent in the obese rats.

    Another main finding was that D2 receptor availability - that is, the
    number of receptors available for binding dopamine - was greater at
    adulthood in the obese rats compared to the lean rats. This suggests
    that perhaps the release of dopamine had significantly decreased with
    age in the obese unrestricted animals more than in the restricted ones
    or the lean rats. The possibility of lower release of dopamine in
    obese subjects is presently being examined, the researchers say.

    This research was funded by the Office of Biological and Environmental
    Research within the U.S. Department of Energy's Office of Science and
    by the Intramural Research Program of the National Institute on
    Alcohol Abuse and Alcoholism, which is part of the National Institutes
    of Health.

    For more information about Peter Thanos's research, see
    http://www.bnl.gov/thanoslab.

    One of ten national laboratories overseen and primarily funded by the
    Office of Science of the U.S. Department of Energy (DOE), Brookhaven
    National Laboratory conducts research in the physical, biomedical, and
    environmental sciences, as well as in energy technologies and national
    security. Brookhaven Lab also builds and operates major scientific
    facilities available to university, industry and government
    researchers. Brookhaven is operated and managed for DOE's Office of
    Science by Brookhaven Science Associates, a limited-liability company
    founded by the Research Foundation of State University of New York on
    behalf of Stony Brook University, the largest academic user of
    Laboratory facilities, and Battelle, a nonprofit, applied science and
    technology organization.

    Visit Brookhaven Lab's electronic newsroom for links, news archives,
    graphics, and more: http://www.bnl.gov/newsroom
    --

    Sheldon

Active in the last 60 minutes

Active in this thread

0 users · 0 guests ·0 bots ·0 total

No signed-in users are active right now.

No known search crawlers active right now.